Covid19, Drug Side Effect, Drug Toxicity, Ivermectin Poisoning
Conditions
Brief summary
retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt
Detailed description
ivermectin was used in Egypt during the pandemic of covid-19 and it was registered in the MOH protocol that has been published in November 2020 the study will document the adverse effects of many patients used ivermectin as aprophylaxis and as a treatment with multiple dose regimens
Interventions
DRUGIvermectin
retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt
Sponsors
Menoufia University
Study design
Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
16 Years to 80 Years
Inclusion criteria
* all people used ivermectin as a treatment or as a prophylactic in covid 19 pandemic in egypt with explained dose
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| all adverse effects will be collected from people used Ivermectin in between September 2020 to December 2020 | the data will be collected from February 2021 to march 2021 | all data will be collected from retrospective manner as a retrospective study |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| all data will be arranged according to time and dose manner | February to match 2021 | data for each dose will be identified together |
Countries
Egypt
Outcome results
None listed